Status:
COMPLETED
Use of Transcranial Direct Current Stimulation (tDCS) Coupled With Constraint Induced Movement Therapy in Stroke Patient
Lead Sponsor:
Spaulding Rehabilitation Hospital
Conditions:
Stroke
Healthy
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether noninvasive brain stimulation associated with motor learning offers an additional benefit than motor learning alone in patients with stroke. The inve...
Detailed Description
In this 3 experiments study we will evaluate the effect of tDCS and constraint induced movement therapy (CIMT) in stroke patients (exp 1) as well as in healthy subjects (control population - exp 2). F...
Eligibility Criteria
Inclusion
- All subjects must be between the ages of 18-90 and must not be pregnant.
- Additional Entry criteria for Stroke subject enrollment:
- First-time clinical ischemic or hemorrhagic cerebrovascular accident - evidenced by a radiological (or physician's) report;
- Weakness, defined as score of less than 55 (out of 66) on arm motor Fugl-Meyer (FM) scale
- Stroke onset \>6 months prior to study enrollment.
Exclusion
- Significant pre-stroke disability;
- Major depression, as defined by Hamilton Depression (HAM-D) scale grater then or equal 17 if needed (history of depression before the stroke);
- Any substantial decrease in alertness, language reception, or attention that might interfere with understanding instructions for motor testing;
- Excessive pain in any joint of the paretic extremity (not applicable to severe stroke subjects);
- Contraindications to single pulse Transcranial Magnetic Stimulation (TMS) (TMS will be used to measure cortical excitability) such as metal head implants
- history of seizures
- unexplained loss of consciousness
- metal in the head
- frequent or severe headaches or neck pain
- implanted brain medical devices.
- Contraindications to tDCS
- metal in the head
- implanted brain medical devices
- Advanced liver, kidney, cardiac, or pulmonary disease;
- A terminal medical diagnosis consistent with survival \< 1 year;
- Coexistent major neurological or psychiatric disease as to decrease number of confounders;
- A history of significant alcohol or drug abuse in the prior 6 months;
- Use of carbamazepine and amitriptyline;
- Subjects may not be actively enrolled in a separate intervention study targeting stroke recovery and
- Subjects may not have already received constraint induced motor therapy and/or tDCS treatment for stroke;
- History of epilepsy before stroke (or episodes of seizures within the last six months).
- Subjects with global aphasia and deficits of comprehension
- Pregnancy
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01143649
Start Date
April 1 2010
End Date
January 1 2016
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spaulding Rehabilitation Hospital
Boston, Massachusetts, United States, 02114